Literature DB >> 12196314

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

Joan Lindsay1, Danielle Laurin, René Verreault, Réjean Hébert, Barbara Helliwell, Gerry B Hill, Ian McDowell.   

Abstract

A prospective analysis of risk factors for Alzheimer's disease was a major objective of the Canadian Study of Health and Aging, a nationwide, population-based study. Of 6,434 eligible subjects aged 65 years or older in 1991, 4,615 were alive in 1996 and participated in the follow-up study. All participants were cognitively normal in 1991 when they completed a risk factor questionnaire. Their cognitive status was reassessed 5 years later by using a similar two-phase procedure, including a screening interview, followed by a clinical examination when indicated. The analysis included 194 Alzheimer's disease cases and 3,894 cognitively normal controls. Increasing age, fewer years of education, and the apolipoprotein E epsilon4 allele were significantly associated with increased risk of Alzheimer's disease. Use of nonsteroidal anti-inflammatory drugs, wine consumption, coffee consumption, and regular physical activity were associated with a reduced risk of Alzheimer's disease. No statistically significant association was found for family history of dementia, sex, history of depression, estrogen replacement therapy, head trauma, antiperspirant or antacid use, smoking, high blood pressure, heart disease, or stroke. The protective associations warrant further study. In particular, regular physical activity could be an important component of a preventive strategy against Alzheimer's disease and many other conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196314     DOI: 10.1093/aje/kwf074

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  328 in total

1.  In Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T.

Authors:  C E Shaaban; H J Aizenstein; D R Jorgensen; R L MacCloud; N A Meckes; K I Erickson; N W Glynn; J Mettenburg; J Guralnik; A B Newman; T S Ibrahim; P J Laurienti; A N Vallejo; C Rosano
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-03       Impact factor: 3.825

2.  ACTIVE cognitive training and rates of incident dementia.

Authors:  Frederick W Unverzagt; Lin T Guey; Richard N Jones; Michael Marsiske; Jonathan W King; Virginia G Wadley; Michael Crowe; George W Rebok; Sharon L Tennstedt
Journal:  J Int Neuropsychol Soc       Date:  2012-03-09       Impact factor: 2.892

Review 3.  Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.

Authors:  Mahyar Etminan; Sudeep Gill; Ali Samii
Journal:  BMJ       Date:  2003-07-19

Review 4.  Impact of estrogen therapy on Alzheimer's disease: a fork in the road?

Authors:  Roberta D Brinton
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

Review 6.  Diet and Alzheimer's disease.

Authors:  José A Luchsinger; James M Noble; Nikolaos Scarmeas
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

7.  The association between physical activity and dementia in an elderly population: the Rotterdam Study.

Authors:  Renée F A G de Bruijn; Elisabeth M C Schrijvers; Karen A de Groot; Jacqueline C M Witteman; Albert Hofman; Oscar H Franco; Peter J Koudstaal; Mohammad Arfan Ikram
Journal:  Eur J Epidemiol       Date:  2013-02-06       Impact factor: 8.082

8.  The association between midlife cardiorespiratory fitness levels and later-life dementia: a cohort study.

Authors:  Laura F Defina; Benjamin L Willis; Nina B Radford; Ang Gao; David Leonard; William L Haskell; Myron F Weiner; Jarett D Berry
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

9.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.

Authors:  Raymond L Ownby; Elizabeth Crocco; Amarilis Acevedo; Vineeth John; David Loewenstein
Journal:  Arch Gen Psychiatry       Date:  2006-05

10.  Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Authors:  Lap Ho; Mario G Ferruzzi; Elsa M Janle; Jun Wang; Bing Gong; Tzu-Ying Chen; Jessica Lobo; Bruce Cooper; Qing Li Wu; Stephen T Talcott; Susan S Percival; James E Simon; Giulio Maria Pasinetti
Journal:  FASEB J       Date:  2012-10-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.